1 Market Overview

1.1 Product Overview and Scope of Specific Antiviral Drugs for COVID-19

1.2 Classification of Specific Antiviral Drugs for COVID-19 by Type

1.2.1 Overview: Global Specific Antiviral Drugs for COVID-19 Market Size by Type: 2022 Versus 2028

1.2.2 Global Specific Antiviral Drugs for COVID-19 Revenue Market Share by Type in 2028

1.2.3 Tablet

1.2.4 Injection

1.3 Global Specific Antiviral Drugs for COVID-19 Market by Application

1.3.1 Overview: Global Specific Antiviral Drugs for COVID-19 Market Size by Application: 2022 Versus 2028

1.3.2 Mild Symptom Patient

1.3.3 Critically Ill Patient

1.4 Global Specific Antiviral Drugs for COVID-19 Market Size & Forecast

1.5 Market Drivers, Restraints and Trends

1.5.1 Specific Antiviral Drugs for COVID-19 Market Drivers

1.5.2 Specific Antiviral Drugs for COVID-19 Market Restraints

1.5.3 Specific Antiviral Drugs for COVID-19 Trends Analysis

2 Company Profiles

2.1 Sanofi

2.1.1 Sanofi Details

2.1.2 Sanofi Major Business

2.1.3 Sanofi Specific Antiviral Drugs for COVID-19 Product and Solutions

2.1.4 Sanofi Recent Developments and Future Plans

2.2 Novartis

2.2.1 Novartis Details

2.2.2 Novartis Major Business

2.2.3 Novartis Specific Antiviral Drugs for COVID-19 Product and Solutions

2.2.4 Novartis Recent Developments and Future Plans

2.3 Shanghai Zhongxisanwei

2.3.1 Shanghai Zhongxisanwei Details

2.3.2 Shanghai Zhongxisanwei Major Business

2.3.3 Shanghai Zhongxisanwei Specific Antiviral Drugs for COVID-19 Product and Solutions

2.3.4 Shanghai Zhongxisanwei Recent Developments and Future Plans

2.4 Teva

2.4.1 Teva Details

2.4.2 Teva Major Business

2.4.3 Teva Specific Antiviral Drugs for COVID-19 Product and Solutions

2.4.4 Teva Recent Developments and Future Plans

2.5 Zydus Cadila

2.5.1 Zydus Cadila Details

2.5.2 Zydus Cadila Major Business

2.5.3 Zydus Cadila Specific Antiviral Drugs for COVID-19 Product and Solutions

2.5.4 Zydus Cadila Recent Developments and Future Plans

2.6 Mylan

2.6.1 Mylan Details

2.6.2 Mylan Major Business

2.6.3 Mylan Specific Antiviral Drugs for COVID-19 Product and Solutions

2.6.4 Mylan Recent Developments and Future Plans

2.7 Apotex

2.7.1 Apotex Details

2.7.2 Apotex Major Business

2.7.3 Apotex Specific Antiviral Drugs for COVID-19 Product and Solutions

2.7.4 Apotex Recent Developments and Future Plans

2.8 Advanz Pharma

2.8.1 Advanz Pharma Details

2.8.2 Advanz Pharma Major Business

2.8.3 Advanz Pharma Specific Antiviral Drugs for COVID-19 Product and Solutions

2.8.4 Advanz Pharma Recent Developments and Future Plans

2.9 Sun Pharma

2.9.1 Sun Pharma Details

2.9.2 Sun Pharma Major Business

2.9.3 Sun Pharma Specific Antiviral Drugs for COVID-19 Product and Solutions

2.9.4 Sun Pharma Recent Developments and Future Plans

2.10 Kyung Poong

2.10.1 Kyung Poong Details

2.10.2 Kyung Poong Major Business

2.10.3 Kyung Poong Specific Antiviral Drugs for COVID-19 Product and Solutions

2.10.4 Kyung Poong Recent Developments and Future Plans

2.11 Ipca Laboratories

2.11.1 Ipca Laboratories Details

2.11.2 Ipca Laboratories Major Business

2.11.3 Ipca Laboratories Specific Antiviral Drugs for COVID-19 Product and Solutions

2.11.4 Ipca Laboratories Recent Developments and Future Plans

2.12 Hanlim Pharmaceutical

2.12.1 Hanlim Pharmaceutical Details

2.12.2 Hanlim Pharmaceutical Major Business

2.12.3 Hanlim Pharmaceutical Specific Antiviral Drugs for COVID-19 Product and Solutions

2.12.4 Hanlim Pharmaceutical Recent Developments and Future Plans

2.13 Bristol Laboratories

2.13.1 Bristol Laboratories Details

2.13.2 Bristol Laboratories Major Business

2.13.3 Bristol Laboratories Specific Antiviral Drugs for COVID-19 Product and Solutions

2.13.4 Bristol Laboratories Recent Developments and Future Plans

2.14 Bayer

2.14.1 Bayer Details

2.14.2 Bayer Major Business

2.14.3 Bayer Specific Antiviral Drugs for COVID-19 Product and Solutions

2.14.4 Bayer Recent Developments and Future Plans

2.15 Rising Pharmaceutical

2.15.1 Rising Pharmaceutical Details

2.15.2 Rising Pharmaceutical Major Business

2.15.3 Rising Pharmaceutical Specific Antiviral Drugs for COVID-19 Product and Solutions

2.15.4 Rising Pharmaceutical Recent Developments and Future Plans

2.16 Shanghai Pharma

2.16.1 Shanghai Pharma Details

2.16.2 Shanghai Pharma Major Business

2.16.3 Shanghai Pharma Specific Antiviral Drugs for COVID-19 Product and Solutions

2.16.4 Shanghai Pharma Recent Developments and Future Plans

2.17 Sichuan Sunny Hope

2.17.1 Sichuan Sunny Hope Details

2.17.2 Sichuan Sunny Hope Major Business

2.17.3 Sichuan Sunny Hope Specific Antiviral Drugs for COVID-19 Product and Solutions

2.17.4 Sichuan Sunny Hope Recent Developments and Future Plans

2.18 Guangzhou Baiyunshan Guanghua Pharmaceutical

2.18.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Details

2.18.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Major Business

2.18.3 Guangzhou Baiyunshan Guanghua Pharmaceutical Specific Antiviral Drugs for COVID-19 Product and Solutions

2.18.4 Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Developments and Future Plans

2.19 CSPC Group

2.19.1 CSPC Group Details

2.19.2 CSPC Group Major Business

2.19.3 CSPC Group Specific Antiviral Drugs for COVID-19 Product and Solutions

2.19.4 CSPC Group Recent Developments and Future Plans

2.20 KPC Group

2.20.1 KPC Group Details

2.20.2 KPC Group Major Business

2.20.3 KPC Group Specific Antiviral Drugs for COVID-19 Product and Solutions

2.20.4 KPC Group Recent Developments and Future Plans

2.21 Jinghua Pharmaceutical Group

2.21.1 Jinghua Pharmaceutical Group Details

2.21.2 Jinghua Pharmaceutical Group Major Business

2.21.3 Jinghua Pharmaceutical Group Specific Antiviral Drugs for COVID-19 Product and Solutions

2.21.4 Jinghua Pharmaceutical Group Recent Developments and Future Plans

2.22 Zhongsheng Pharma

2.22.1 Zhongsheng Pharma Details

2.22.2 Zhongsheng Pharma Major Business

2.22.3 Zhongsheng Pharma Specific Antiviral Drugs for COVID-19 Product and Solutions

2.22.4 Zhongsheng Pharma Recent Developments and Future Plans

2.23 North China Pharmaceutical Group

2.23.1 North China Pharmaceutical Group Details

2.23.2 North China Pharmaceutical Group Major Business

2.23.3 North China Pharmaceutical Group Specific Antiviral Drugs for COVID-19 Product and Solutions

2.23.4 North China Pharmaceutical Group Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Specific Antiviral Drugs for COVID-19 Revenue and Share by Players (2022 & 2028)

3.2 Specific Antiviral Drugs for COVID-19 Players Head Office, Products and Services Provided

3.3 Specific Antiviral Drugs for COVID-19 Mergers & Acquisitions

3.4 Specific Antiviral Drugs for COVID-19 New Entrants and Expansion Plans

4 Global Specific Antiviral Drugs for COVID-19 Forecast by Region

4.1 Global Specific Antiviral Drugs for COVID-19 Market Size by Region: 2022 VS 2028

4.2 Global Specific Antiviral Drugs for COVID-19 Market Size by Region, (2022-2028)

4.3 North America

4.3.1 Key Companies of Specific Antiviral Drugs for COVID-19 in North America

4.3.2 Current Situation and Forecast of Specific Antiviral Drugs for COVID-19 in North America

4.3.3 North America Specific Antiviral Drugs for COVID-19 Market Size and Prospect (2022-2028)

4.4 Europe

4.4.1 Key Companies of Specific Antiviral Drugs for COVID-19 in Europe

4.4.2 Current Situation and Forecast of Specific Antiviral Drugs for COVID-19 in Europe

4.4.3 Europe Specific Antiviral Drugs for COVID-19 Market Size and Prospect (2022-2028)

4.5 Asia-Pacific

4.5.1 Key Companies of Specific Antiviral Drugs for COVID-19 in Asia-Pacific

4.5.2 Current Situation and Forecast of Specific Antiviral Drugs for COVID-19 in Asia-Pacific

4.5.3 Asia-Pacific Specific Antiviral Drugs for COVID-19 Market Size and Prospect (2022-2028)

4.6 South America

4.6.1 Key Companies of Specific Antiviral Drugs for COVID-19 in South America

4.6.2 Current Situation and Forecast of Specific Antiviral Drugs for COVID-19 in South America

4.6.3 South America Specific Antiviral Drugs for COVID-19 Market Size and Prospect (2022-2028)

4.7 Middle East & Africa

4.7.1 Key Companies of Specific Antiviral Drugs for COVID-19 in Middle East & Africa

4.7.2 Current Situation and Forecast of Specific Antiviral Drugs for COVID-19 in Middle East & Africa

4.7.3 Middle East & Africa Specific Antiviral Drugs for COVID-19 Market Size and Prospect (2022-2028)

5 Market Size Segment by Type

5.1 Global Specific Antiviral Drugs for COVID-19 Market Forecast by Type (2022-2028)

5.2 Global Specific Antiviral Drugs for COVID-19 Market Share Forecast by Type (2022-2028)

6 Market Size Segment by Application

6.1 Global Specific Antiviral Drugs for COVID-19 Market Forecast by Application (2022-2028)

6.2 Global Specific Antiviral Drugs for COVID-19 Market Share Forecast by Application (2022-2028)

7 Research Findings and Conclusion

8 Appendix

8.1 Methodology

8.2 Research Process and Data Source

8.3 Disclaimer

List of Tables

Table 1. Global Specific Antiviral Drugs for COVID-19 Revenue by Type, (USD Million), 2022 VS 2028

Table 2. Global Specific Antiviral Drugs for COVID-19 Revenue by Application, (USD Million), 2022 VS 2028

Table 3. Sanofi Corporate Information, Head Office, and Major Competitors

Table 4. Sanofi Major Business

Table 5. Sanofi Specific Antiviral Drugs for COVID-19 Product and Solutions

Table 6. Novartis Corporate Information, Head Office, and Major Competitors

Table 7. Novartis Major Business

Table 8. Novartis Specific Antiviral Drugs for COVID-19 Product and Solutions

Table 9. Shanghai Zhongxisanwei Corporate Information, Head Office, and Major Competitors

Table 10. Shanghai Zhongxisanwei Major Business

Table 11. Shanghai Zhongxisanwei Specific Antiviral Drugs for COVID-19 Product and Solutions

Table 12. Teva Corporate Information, Head Office, and Major Competitors

Table 13. Teva Major Business

Table 14. Teva Specific Antiviral Drugs for COVID-19 Product and Solutions

Table 15. Zydus Cadila Corporate Information, Head Office, and Major Competitors

Table 16. Zydus Cadila Major Business

Table 17. Zydus Cadila Specific Antiviral Drugs for COVID-19 Product and Solutions

Table 18. Mylan Corporate Information, Head Office, and Major Competitors

Table 19. Mylan Major Business

Table 20. Mylan Specific Antiviral Drugs for COVID-19 Product and Solutions

Table 21. Apotex Corporate Information, Head Office, and Major Competitors

Table 22. Apotex Major Business

Table 23. Apotex Specific Antiviral Drugs for COVID-19 Product and Solutions

Table 24. Advanz Pharma Corporate Information, Head Office, and Major Competitors

Table 25. Advanz Pharma Major Business

Table 26. Advanz Pharma Specific Antiviral Drugs for COVID-19 Product and Solutions

Table 27. Sun Pharma Corporate Information, Head Office, and Major Competitors

Table 28. Sun Pharma Major Business

Table 29. Sun Pharma Specific Antiviral Drugs for COVID-19 Product and Solutions

Table 30. Kyung Poong Corporate Information, Head Office, and Major Competitors

Table 31. Kyung Poong Major Business

Table 32. Kyung Poong Specific Antiviral Drugs for COVID-19 Product and Solutions

Table 33. Ipca Laboratories Corporate Information, Head Office, and Major Competitors

Table 34. Ipca Laboratories Major Business

Table 35. Ipca Laboratories Specific Antiviral Drugs for COVID-19 Product and Solutions

Table 36. Hanlim Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 37. Hanlim Pharmaceutical Major Business

Table 38. Hanlim Pharmaceutical Specific Antiviral Drugs for COVID-19 Product and Solutions

Table 39. Bristol Laboratories Corporate Information, Head Office, and Major Competitors

Table 40. Bristol Laboratories Major Business

Table 41. Bristol Laboratories Specific Antiviral Drugs for COVID-19 Product and Solutions

Table 42. Bayer Corporate Information, Head Office, and Major Competitors

Table 43. Bayer Major Business

Table 44. Bayer Specific Antiviral Drugs for COVID-19 Product and Solutions

Table 45. Rising Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 46. Rising Pharmaceutical Major Business

Table 47. Rising Pharmaceutical Specific Antiviral Drugs for COVID-19 Product and Solutions

Table 48. Shanghai Pharma Corporate Information, Head Office, and Major Competitors

Table 49. Shanghai Pharma Major Business

Table 50. Shanghai Pharma Specific Antiviral Drugs for COVID-19 Product and Solutions

Table 51. Sichuan Sunny Hope Corporate Information, Head Office, and Major Competitors

Table 52. Sichuan Sunny Hope Major Business

Table 53. Sichuan Sunny Hope Specific Antiviral Drugs for COVID-19 Product and Solutions

Table 54. Guangzhou Baiyunshan Guanghua Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 55. Guangzhou Baiyunshan Guanghua Pharmaceutical Major Business

Table 56. Guangzhou Baiyunshan Guanghua Pharmaceutical Specific Antiviral Drugs for COVID-19 Product and Solutions

Table 57. CSPC Group Corporate Information, Head Office, and Major Competitors

Table 58. CSPC Group Major Business

Table 59. CSPC Group Specific Antiviral Drugs for COVID-19 Product and Solutions

Table 60. KPC Group Corporate Information, Head Office, and Major Competitors

Table 61. KPC Group Major Business

Table 62. KPC Group Specific Antiviral Drugs for COVID-19 Product and Solutions

Table 63. Jinghua Pharmaceutical Group Corporate Information, Head Office, and Major Competitors

Table 64. Jinghua Pharmaceutical Group Major Business

Table 65. Jinghua Pharmaceutical Group Specific Antiviral Drugs for COVID-19 Product and Solutions

Table 66. Zhongsheng Pharma Corporate Information, Head Office, and Major Competitors

Table 67. Zhongsheng Pharma Major Business

Table 68. Zhongsheng Pharma Specific Antiviral Drugs for COVID-19 Product and Solutions

Table 69. North China Pharmaceutical Group Corporate Information, Head Office, and Major Competitors

Table 70. North China Pharmaceutical Group Major Business

Table 71. North China Pharmaceutical Group Specific Antiviral Drugs for COVID-19 Product and Solutions

Table 72. Global Specific Antiviral Drugs for COVID-19 Revenue (USD Million) by Players (2022 & 2028)

Table 73. Global Specific Antiviral Drugs for COVID-19 Revenue Share by Players (2022 & 2028)

Table 74. Specific Antiviral Drugs for COVID-19 Players Head Office, Products and Services Provided

Table 75. Specific Antiviral Drugs for COVID-19 Mergers & Acquisitions in the Past Five Years

Table 76. Specific Antiviral Drugs for COVID-19 New Entrants and Expansion Plans

Table 77. Global Market Specific Antiviral Drugs for COVID-19 Revenue (USD Million) Comparison by Region (2022 VS 2028)

Table 78. Global Specific Antiviral Drugs for COVID-19 Revenue Market Share by Region (2022-2028)

Table 79. Key Companies of Specific Antiviral Drugs for COVID-19 in North America

Table 80. Current Situation and Forecast of Specific Antiviral Drugs for COVID-19 in North America

Table 81. Key Companies of Specific Antiviral Drugs for COVID-19 in Europe

Table 82. Current Situation and Forecast of Specific Antiviral Drugs for COVID-19 in Europe

Table 83. Key Companies of Specific Antiviral Drugs for COVID-19 in Asia-Pacific

Table 84. Current Situation and Forecast of Specific Antiviral Drugs for COVID-19 in Asia-Pacific

Table 85. Key Companies of Specific Antiviral Drugs for COVID-19 in China

Table 86. Key Companies of Specific Antiviral Drugs for COVID-19 in Japan

Table 87. Key Companies of Specific Antiviral Drugs for COVID-19 in South Korea

Table 88. Key Companies of Specific Antiviral Drugs for COVID-19 in South America

Table 89. Current Situation and Forecast of Specific Antiviral Drugs for COVID-19 in South America

Table 90. Key Companies of Specific Antiviral Drugs for COVID-19 in Middle East & Africa

Table 91. Current Situation and Forecast of Specific Antiviral Drugs for COVID-19 in Middle East & Africa

Table 92. Global Specific Antiviral Drugs for COVID-19 Revenue Forecast by Type (2022-2028)

Table 93. Global Specific Antiviral Drugs for COVID-19 Revenue Forecast by Application (2022-2028)

List of Figures

Figure 1. Specific Antiviral Drugs for COVID-19 Picture

Figure 2. Global Specific Antiviral Drugs for COVID-19 Revenue Market Share by Type in 2028

Figure 3. Tablet

Figure 4. Injection

Figure 5. Specific Antiviral Drugs for COVID-19 Revenue Market Share by Application in 2028

Figure 6. Mild Symptom Patient Picture

Figure 7. Critically Ill Patient Picture

Figure 8. Global Specific Antiviral Drugs for COVID-19 Market Size, (USD Million): 2022 VS 2028

Figure 9. Global Specific Antiviral Drugs for COVID-19 Revenue and Forecast (2022-2028) & (USD Million)

Figure 10. Specific Antiviral Drugs for COVID-19 Market Drivers

Figure 11. Specific Antiviral Drugs for COVID-19 Market Restraints

Figure 12. Specific Antiviral Drugs for COVID-19 Market Trends

Figure 13. Sanofi Recent Developments and Future Plans

Figure 14. Novartis Recent Developments and Future Plans

Figure 15. Shanghai Zhongxisanwei Recent Developments and Future Plans

Figure 16. Teva Recent Developments and Future Plans

Figure 17. Zydus Cadila Recent Developments and Future Plans

Figure 18. Mylan Recent Developments and Future Plans

Figure 19. Apotex Recent Developments and Future Plans

Figure 20. Advanz Pharma Recent Developments and Future Plans

Figure 21. Sun Pharma Recent Developments and Future Plans

Figure 22. Kyung Poong Recent Developments and Future Plans

Figure 23. Ipca Laboratories Recent Developments and Future Plans

Figure 24. Hanlim Pharmaceutical Recent Developments and Future Plans

Figure 25. Bristol Laboratories Recent Developments and Future Plans

Figure 26. Bayer Recent Developments and Future Plans

Figure 27. Rising Pharmaceutical Recent Developments and Future Plans

Figure 28. Shanghai Pharma Recent Developments and Future Plans

Figure 29. Sichuan Sunny Hope Recent Developments and Future Plans

Figure 30. Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Developments and Future Plans

Figure 31. CSPC Group Recent Developments and Future Plans

Figure 32. KPC Group Recent Developments and Future Plans

Figure 33. Jinghua Pharmaceutical Group Recent Developments and Future Plans

Figure 34. Zhongsheng Pharma Recent Developments and Future Plans

Figure 35. North China Pharmaceutical Group Recent Developments and Future Plans

Figure 36. Global Specific Antiviral Drugs for COVID-19 Revenue Market Share by Region (2022-2028)

Figure 37. Global Specific Antiviral Drugs for COVID-19 Revenue Market Share by Region in 2028

Figure 38. North America Specific Antiviral Drugs for COVID-19 Revenue (USD Million) and Growth Rate (2022-2028)

Figure 39. Europe Specific Antiviral Drugs for COVID-19 Revenue (USD Million) and Growth Rate (2022-2028)

Figure 40. Asia-Pacific Specific Antiviral Drugs for COVID-19 Revenue (USD Million) and Growth Rate (2022-2028)

Figure 41. South America Specific Antiviral Drugs for COVID-19 Revenue (USD Million) and Growth Rate (2022-2028)

Figure 42. Middle East & Africa Specific Antiviral Drugs for COVID-19 Revenue (USD Million) and Growth Rate (2022-2028)

Figure 43. Global Specific Antiviral Drugs for COVID-19 Market Share Forecast by Type (2022-2028)

Figure 44. Global Specific Antiviral Drugs for COVID-19 Market Share Forecast by Application (2022-2028)

Figure 45. Methodology

Figure 46. Research Process and Data Source